سيرينيا محلول للحقن
Cerenia (maropitant citrate) Injectable Solution is a neurokinin-1 (NK1) receptor antagonist indicated for the prevention and treatment of acute vomiting in dogs and cats, as well as prevention of vomiting associated with emetogenic medications.
الشكل الصيدلاني
Injection
نوع المنتج
دواء
الشركة المصنعة
الحجم
20 mL amber glass multi-dose vial containing 10 mg/mL maropitant
| النوع الحيواني | الجرعة | طريقة الإعطاء | المدة |
|---|---|---|---|
| Dog | 1.0 mg/kg (0.1 mL/10 kg) | Subcutaneous (SC) or Intravenous (IV) | Once daily for up to 5 consecutive days |
| Cat | 1.0 mg/kg (0.1 mL/10 kg) | Subcutaneous (SC) or Intravenous (IV) | Once daily for up to 5 consecutive days |
لا توجد معلومات سحب متاحة.
Prevention and treatment of acute vomiting in dogs and cats.
Prevention of vomiting associated with pre-anesthetic use of emetogenic medications (such as morphine or hydromorphone) in dogs.
Do not use in animals with known hypersensitivity to maropitant.
Do not use in puppies under 8 weeks of age or kittens under 16 weeks of age.
Use with caution in animals with suspected or known gastrointestinal foreign body or obstruction.
Use with caution in patients with hepatic dysfunction, as maropitant is primarily metabolized by the liver.
Safety has not been evaluated in breeding, pregnant, or lactating dogs or cats.
Pain or stinging sensation at the subcutaneous injection site.
Lethargy, anorexia, diarrhea, or ataxia in rare cases.
Cerenia Injectable Prescribing Information
نشرة10 mg/mL
لا توجد أمراض مرتبطة.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
شركة مصنعة
لا توجد بدائل متاحة.